August 2006

 

Issue

SPECIAL REPORT: EVAR IN HIGH-RISK PATIENTS

A Critical Review of Outcomes

Gregorio A. Sicard, MD, explains the origin of the SVS Outcomes Committee and its current initiatives, including examination of high-risk patient data from the US IDE endovascular aneurysm repair trials.

By Gregorio A. Sicard, MD

First Among Equals

Professor Roger Greenhalgh, Professor Janet Powell, and Louise Brown address outside interpretations of the design and conclusions of the EVAR-2 trial.

By Professor Roger Greenhalgh, Professor Janet Powell, and Louise Brown

The Impact of Outcomes

Rodney A. White, MD, discusses the goals of the SVS Outcomes Committee, issues in reimbursement, and assessments of high-risk patient outcomes data.

By Rodney A. White, MD

Making Sense of Apples-to-Oranges Comparisons

K. Craig Kent, MD, describes the advantages and disadvantages of each of the available datasets on endovascular repair in high-risk patients, including what has been learned from the extensive Medicare database.

By K. Craig Kent, MD

Issues in Comparative High-Risk Datasets

Roy K. Greenberg, MD, explains the Cleveland Clinic's experiences with high-risk aneurysm patients, the limitations of current comparative analyses, and the search for predictors of mortality.

By Roy K. Greenberg, MD

Evaluating Outcomes in Context

Robert Zwolak, MD, discusses his work with the SVS Outcomes Committee, the role of AHRQ, and his perspective on contemporary endovascular aneurysm trials.

By Robert Zwolak, MD

The Regulatory Perspective

Dorothy B. Abel discusses the FDA's considerations and its role regarding trial data.

By Dorothy B. Abel

DIALYSIS ROUNDTABLE

Dialysis Roundtable

A panel of interventional radiologists discusses the issues and controversies surrounding hemodialysis, and the use of catheters, fistulae, and grafts as access.

By Abigail Falk, MD; Ziv Haskal, MD; Matthew S. Johnson, MD; Gordon McLennan, MD; and Tom Vesely, MD

COVER STORY

Anatomic and Technical Considerations of CAS

Patient selection, choice of devices, and guidelines for avoiding complications in successful carotid stent placement.

By Mark H. Wholey, MD

Assessing the Learning Curve of CAS

Lessons learned from 246 carotid artery stenting procedures.

By Peter H. Lin, MD; Wei Zhou, MD; Panos Kougias, MD; Hosam El Sayed, MD; and Alan B. Lumsden, MD

Operator Experience Versus Embolic Protection in the Carotid Arteries

A review of the data regarding the theoretical advantages of embolic protection devices over unprotected CAS procedures.

By James A.M. Smith, DO

Overview of Vulnerable Plaque

An overview of the characteristics, detection methods, and response to treatment of vulnerable plaque in the carotids

By Emile R. Mohler III, MD

Neuroprotection for Ostial Common Carotid Stenoses

The "double-wire" technique is an effective method of treating these complex lesions.

By James Joye, DO

Pixel Distribution Analysis to Identify Unstable Carotid Plaques

Is carotid plaque morphology ready for prime time?

By Brajesh K. Lal, MD, and Robert W. Hobson II, MD

Update on the TACIT Trial

New endpoints and new data have made TACIT even more critical.

By Endovascular Today interviews John H. Rundback, MD

An Interview with John R. Laird, Jr, MD

EVT's Chief Interventional Cardiologist discusses his move to UC Davis, his most rewarding procedures, and VIVA 2006.

By John R. Laird, Jr, MD
 

Contact Info

For advertising rates and opportunities, contact:
Craig McChesney
484-581-1816
cmcchesney@bmctoday.com

Stephen Hoerst
484-581-1817
shoerst@bmctoday.com

Charles Philip
484-581-1873
cphillip@bmctoday.com

About Endovascular Today

Endovascular Today is a publication dedicated to bringing you comprehensive coverage of all the latest technology, techniques, and developments in the endovascular field. Our Editorial Advisory Board is composed of the top endovascular specialists, including interventional cardiologists, interventional radiologists, vascular surgeons, neurologists, and vascular medicine practitioners, and our publication is read by an audience of more than 22,000 members of the endovascular community.